Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today it will present at the ROTH Capital Healthcare Event, “COVID-19 Therapeutics in Development” taking place on Wednesday, October 28, 2020 – 9:00 AM (ET) / 6:00 AM (PT).
October 27, 2020
· 2 min read